Updated just now · Live
Stock analysis, price data, and AI-powered insights for Maia Biotechnology Inc (MAIA).
Maia Biotechnology Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for MAIA.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). MAIA Stock Intelligence Report. [stoxpulse.com/stocks/maia]
Disclaimer: The information on this page about Maia Biotechnology Inc (MAIA) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Maia Biotechnology Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
MAIA Biotechnology Activates First U.S. Site for O...
5d ago
MAIA Biotechnology Activates First Clinical Facili...
5d ago
StoxPulse AI results for MAIA: Pulse Score 53/100. Primary sentiment trends from 2 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$85.5M
P/E Ratio
—
EPS
$-0.27
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer
MAIA Biotechnology Activates First Clinical Facility In U.S. In Its Phase 2 THIO-101 Expansion Study To Treat Non-Small Cell Lung Cancer